MAGNETOM Sola, MAGNETOM Altea, MAGNETOM Sola Fit

K221733 · Siemens Medical Solutions USA, Inc. · LNH · Sep 13, 2022 · Radiology

Device Facts

Record IDK221733
Device NameMAGNETOM Sola, MAGNETOM Altea, MAGNETOM Sola Fit
ApplicantSiemens Medical Solutions USA, Inc.
Product CodeLNH · Radiology
Decision DateSep 13, 2022
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 892.1000
Device ClassClass 2

Intended Use

The MAGNETOM system is indicated for use as a magnetic resonance diagnostic device (MRDD) that produces transverse, sagittal, coronal and oblique cross sectional images, spectroscopic images and/or spectra, and that displays the internal structure and/or function of the head, body, or extremities. Other physical parameters derived from the images and/or spectra may also be produced. Depending on the region of interest, contrast agents may be used. These images and/or spectra and the physical parameters derived from the images and/or spectra when interpreted by a trained physician yield information that may assist in diagnosis. The MAGNETOM system may also be used for imaging during interventional procedures when performed with MR compatible devices such as in-room displays and MR Safe biopsy needles.

Device Story

MAGNETOM Sola, Altea, and Sola Fit are MRI systems using syngo MR XA51A software. Inputs include patient physiological signals and MR imaging data. Features include myExam 3D Camera for patient positioning; myExam Autopilot for simplified routine Brain/Knee scan workflows; myExam Angio Advanced Assist for peripheral angiography planning; and Beat Sensor Cardiac triggering using pilot tone technology. Open Recon Framework allows container-based reconstruction using FDA-cleared 3rd party algorithms. Operated by radiographers/technicians in clinical settings; images interpreted by physicians to assist in diagnosis. Benefits include improved workflow efficiency, standardized scan quality for less experienced users, and enhanced cardiac triggering capabilities.

Clinical Evidence

No clinical tests were conducted. Substantial equivalence supported by non-clinical software verification and validation, electrical/mechanical safety testing (IEC 60601-1, IEC 60601-2-33), and EMC testing (IEC 60601-1-2). Sample clinical images were provided.

Technological Characteristics

Magnetic resonance diagnostic device. Features myExam 3D Camera, pilot tone-based cardiac triggering, and Open Recon Framework for containerized reconstruction. Conforms to IEC 62304 (software), ISO 14971 (risk management), IEC 60601-1 (safety), and IEC 60601-2-33 (MR safety).

Indications for Use

Indicated for patients requiring diagnostic MRI of the head, body, or extremities to visualize internal structure and function. Used for diagnostic imaging and interventional procedures with MR-compatible devices.

Regulatory Classification

Identification

A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).

Special Controls

*Classification.* Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo for the U.S. Food and Drug Administration (FDA). On the left is the Department of Health and Human Services logo. To the right of that is the FDA logo, with the letters "FDA" in a blue box, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text. September 13, 2022 Siemens Medical Solutions USA, Inc. % Alina Goodman Regulatory Affairs Professional 40 Liberty Boulevard MALVERN PA 19355 #### Re: K221733 Trade/Device Name: MAGNETOM Sola, MAGNETOM Altea, MAGNETOM Sola Fit Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic resonance diagnostic device Regulatory Class: Class II Product Code: LNH, LNI, MOS Dated: June 9, 2022 Received: June 15, 2022 #### Dear Alina Goodman: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting {1}------------------------------------------------ combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, ## Daniel M. Krainak, Ph.D. Assistant Director Magnetic Resonance and Nuclear Medicine Team DHT8C: Division of Radiological Imaging and Radiation Therapy Devices OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use Submission Number (if known) #### K221733 Device Name MAGNETOM Sola; MAGNETOM Altea; MAGNETOM Sola Fit Indications for Use (Describe) The MAGNETOM system is indicated for use as a magnetic resonance diagnostic device (MRDD) that produces transverse, sagittal, coronal and oblique cross sectional images, spectroscopic images and/or spectra, and that displays the internal structure and/or function of the head, body, or extremities. Other physical parameters derived from the images and/or spectra may also be produced. Depending on the region of interest, contrast agents may be used. These images and/or spectra and the physical parameters derived from the images and/or spectra when interpreted by a trained physician vield information that may assist in diagnosis. The MAGNETOM system may also be used for imaging during interventional procedures when performed with MR compatible devices such as in-room displays and MR Safe biopsy needles. Type of Use (Select one or both, as applicable) type of Use (Select *one* or *both*, as applicable) < Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ # 510(k) Summary This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of the Safe Medical Devices Act 1990 and 21 CFR § 807.92. #### 1. General Information | Establishment: | Siemens Medical Solutions USA, Inc.<br>40 Liberty Boulevard<br>Malvern, PA 19355, USA<br>Registration Number: 2240869 | |----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Date Prepared: | June 9th, 2022 | | Manufacturer: | Siemens Healthcare GmbH<br>Henkestr. 127<br>91052 Erlangen<br>Germany<br>Registration Number: 3002808157<br>Siemens Shenzhen Magnetic Resonance<br>Siemens MRI Center | LTD. Hi-Tech Industrial park (middle) Gaoxin C. Ave., 2nd Shenzhen 518057 P.R. CHINA Registration Number: 3004754211 #### 2. Contact Information Alina Goodman Regulatory Affairs Professional Siemens Medical Solutions USA, Inc. 40 Liberty Boulevard Malvern, PA 19355, USA Phone: +1(317)371-8593 E-mail: alina.goodman@siemens-healthineers.com #### 3. Device Name and Classification | Device/ Trade name: | MAGNETOM Sola, MAGNETOM Altea, MAGNETOM<br>Sola Fit with syngo MR XA51A | |-----------------------|-------------------------------------------------------------------------| | Classification Name: | Magnetic Resonance Diagnostic Device (MRDD) | | Classification Panel: | Radiology | | CFR Code: | 21 CFR § 892.1000 | | Classification: | II | | Product Code: | Primary: LNH<br>Secondary: LNI, MOS | {4}------------------------------------------------ #### 4. Legally Marketed Predicate Device | Trade name: | MAGNETOM Vida with syngo MR XA50A | |-----------------------|---------------------------------------------| | 510(k) Number: | K213693 | | Classification Name: | Magnetic Resonance Diagnostic Device (MRDD) | | Classification Panel: | Radiology | | CFR Code: | 21 CFR § 892.1000 | | Classification: | II | | Product Code: | Primary: LNH<br>Secondary: LNI, MOS | #### 5. Intended Use The indications for use for the subject devices are the same as the predicate device: The MAGNETOM system is indicated for use as a magnetic resonance diagnostic device (MRDD) that produces transverse, sagittal, coronal and oblique cross sectional images, spectroscopic images and/or spectra, and that displays the internal structure and/or function of the head, body, or extremities. Other physical parameters derived from the images and/or spectra may also be produced. Depending on the region of interest, contrast agents may be used. These images and/or spectra and the physical parameters derived from the images and/or spectra when interpreted by a trained physician yield information that may assist in diagnosis. The MAGNETOM system may also be used for imaging during interventional procedures when performed with MR compatible devices such as in-room displays and MR Safe biopsy needles. ## 6. Device Description The subject devices, MAGNETOM Sola, MAGNETOM Altea, MAGNETOM Sola Fit with software syngo MR XA51A, consist of new and modified software and hardware that is similar to what is currently offered on the predicate device, MAGNETOM Vida with syngo MR XA50A (K213693). A high-level summary of the new and modified hardware and software is provided below: #### Hardware New Features and Application - The myExam 3D Camera feature supports the radiographer and/or the technician with the positioning of the patient during the examination ## Software New Features and Applications - myExam Autopilot is a simplified scan workflow designed for enabling less-MRI experience users to complete MRI routine Brain and Knee examinations successfully. - Open Recon Framework interface allows to apply container-based reconstruction algorithms on the reconstruction systems. The Open Recon Framework only allows FDA cleared 3rd party algorithms to be imported for clinical use. #### Modified Features and Applications - myExam Angio Advanced Assist for Test Bolus examinations supports the clinical user in planning and execution of peripheral angiography examinations. {5}------------------------------------------------ The user is quided in the multi-station planning and the correct timing of the angiography measurement using the Angio Advanced Bolus Timing Addin. - Beat Sensor Cardiac triggering is a physiological triggering technique based on the pilot tone technology that has been adapted in the subject devices to allow for cardiac triggering with a wide range of sequences typically used in MRI examinations of the heart and great vessels ## 7. Substantial Equivalence MAGNETOM Sola, MAGNETOM Altea, MAGNETOM Sola Fit with software syngo MR XA51A is substantially equivalent to the following predicate device: | Predicate Device | FDA Clearance Number<br>and Date | Product<br>Code | Manufacturer | |--------------------|----------------------------------|-----------------|--------------------| | MAGNETOM Vida with | K213693, cleared on | LNH | Siemens Healthcare | | syngo MR XA50A | February 25, 2022 | LNI, MOS | GmbH | ## 8. Technological Characteristics The subject devices, MAGNETOM Sola, MAGNETOM Altea, MAGNETOM Sola Fit with software synqo MR XA51A, are substantially equivalent to the predicate device with regard to the operational environment, programming language, operating system and performance. The subject devices conform to the standard for medical device software (IEC 62304) and other relevant IEC and NEMA standards. There are some differences in technological characteristics between the subject device and predicate device, including new and modified hardware/software. These differences have been tested and the conclusion from the non-clinical data suggests that the features bear an equivalent safety and performance profile to that of the predicate device. ## 9. Nonclinical Tests The following performance testing was conducted on the subject devices. | Performance Test | Tested<br>Hardware or<br>Software | Source/Rationale<br>for test | Acceptance<br>Criteria | Overall<br>Result | For Details<br>please refer to | |--------------------------------------------------------------------------|----------------------------------------------------|---------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|-------------------|-------------------------------------| | Software verification<br>and validation | mainly new<br>and modified<br>software<br>features | Guidance for the<br>Content of<br>Premarket<br>Submissions for<br>Software<br>Contained in<br>Medical Devices | Verification<br>and<br>Validation<br>tests are met | Passed | V&V-List<br>see Attachment<br>10-4 | | Electrical, mechanical,<br>structural, and related<br>system safety test | complete<br>system | - AAMI / ANSI<br>ES60601-1<br>- IEC 60601-2-33 | Tests<br>according to<br>applicable<br>standard are<br>met/passed | Passed | IEC testing<br>see Attachment<br>12 | | Electrical safety and<br>electromagnetic<br>compatibility (EMC) | complete<br>system | IEC 60601-1-2 | EMC<br>requirements<br>are<br>met/passed | Passed | IEC testing<br>see Attachment<br>12 | {6}------------------------------------------------ The results from each set of tests demonstrate that the devices perform as intended and are thus substantially equivalent to the predicate device to which it has been compared. #### 10.Clinical Tests / Publications No additional clinical tests were conducted to support substantial equivalence for the subject devices; however, as stated above, sample clinical images were provided. Furthermore, no additional clinical publications were needed referenced to provide information on the use of the following features and functions, since this was sufficiently done for the predicate device. #### 11.Safety and Effectiveness The device labeling contains instructions for use and any necessary cautions and warnings to ensure safe and effective use of the device. Risk Management is ensured via a risk analysis in compliance with ISO 14971, to identify and provide mitigation of potential hazards early in the design cycle and continuously throughout the development of the product. Siemens Healthcare GmbH adheres to recognized and established industry standards, such as the IEC 60601-1 series, to minimize electrical and mechanical hazards. Furthermore, the device is intended for healthcare professionals familiar with and responsible for the acquisition and post processing of magnetic resonance images. MAGNETOM Sola, MAGNETOM Altea, MAGNETOM Sola Fit with software syngo MR XA51A conforms to the following FDA recognized and international IEC, ISO and NEMA standards: | Recognition<br>Number | Product<br>Area | Title of Standard | Reference<br>Number and date | Standards<br>Development<br>Organization | |-----------------------|----------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------|------------------------------------------| | 19-4 | General II<br>(ES/<br>EMC) | Medical electrical equipment -<br>Part 1: General requirements for<br>basic safety and essential<br>performance (IEC 60601-<br>1:2005, MOD) | ES60601-<br>1:2005/(R)2012<br>and A1:2012,<br>C1:2009/(R)2012<br>and<br>A2:2010/(R)2012<br>(Consolidated Text) | ANSI AAMI | | 12-295 | Radiology | Medical electrical equipment -<br>Part 2-33: Particular<br>requirements for the basic<br>safety and essential<br>performance of magnetic<br>resonance equipment for<br>medical diagnosis | 60601-2-33 Ed. 3.2<br>b:2015 | IEC | | 5-40 | General I<br>(QS/<br>RM) | Medical devices - Application of<br>risk management to medical<br>devices | 14971 Second<br>edition 2007-03-01 | ISO | | 5-114 | General I<br>(QS/<br>RM) | Medical devices - Part 1:<br>Application of usability<br>engineering to medical devices | 62366-1:2015 | ANSI AAMI<br>IEC | | 13-79 | Software/<br>Informatics | Medical device software -<br>Software life cycle processes | 62304 Edition 1.1<br>2015-06<br>CONSOLIDATED<br>VERSION | IEC | {7}------------------------------------------------ #### 12.Conclusion as to Substantial Equivalence MAGNETOM Sola, MAGNETOM Altea, MAGNETOM Sola Fit with software syngo MR XA51A has the same intended use and same basic technological characteristics than the predicate device system, MAGNETOM Vida with syngo MR XA50A, with respect to the magnetic resonance features and functionalities. While there are some differences in technical features compared to the predicate device, the differences have been tested and the conclusions from all verification and validation data suggest that the features bear an equivalent safety and performance profile to that of the predicate device and reference devices. Siemens believes that MAGNETOM Sola, MAGNETOM Altea, MAGNETOM Sola Fit with software syngo MR XA51A is substantially equivalent to the currently marketed device MAGNETOM Vida with software syngo MR XA50A (K213693, cleared on February 25, 2022).
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%